| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1052542459 |
| P356 | DOI | 10.1186/S12888-016-0931-5 |
| P932 | PMC publication ID | 4973535 |
| P698 | PubMed publication ID | 27491674 |
| P50 | author | Michael Barkham | Q39993676 |
| Daphne Kaklamanou | Q47222808 | ||
| Daniel Hind | Q53976323 | ||
| P2093 | author name string | Cindy Cooper | |
| Dan Beever | |||
| Ellen Lee | |||
| Rosie Webster | |||
| P2860 | cites work | Grey literature in meta-analyses of randomized trials of health care interventions | Q24245582 |
| Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology | Q24615757 | ||
| Depression in multiple sclerosis: a review | Q24670409 | ||
| The Measurement of Observer Agreement for Categorical Data | Q26778373 | ||
| Multiple sclerosis | Q28299151 | ||
| Coefficient alpha and the internal structure of tests | Q29042519 | ||
| Systematic reviews in health care: Assessing the quality of controlled clinical trials | Q29618659 | ||
| Systematic review of the empirical evidence of study publication bias and outcome reporting bias | Q29619094 | ||
| Searching multiple databases for systematic reviews: added value or diminishing returns? | Q31141370 | ||
| Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis | Q33760818 | ||
| The COMET Initiative database: progress and activities from 2011 to 2013. | Q33938597 | ||
| Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors | Q34389549 | ||
| Measuring quality of life in mental health: are we asking the right questions? | Q34473382 | ||
| Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science | Q35206125 | ||
| A review about the impact of multiple sclerosis on health-related quality of life | Q35583727 | ||
| What is missing from descriptions of treatment in trials and reviews? | Q37201306 | ||
| Evaluation of the methodological quality of systematic reviews of health status measurement instruments | Q37400027 | ||
| The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies | Q38007587 | ||
| Searching CINAHL did not add value to clinical questions posed in NICE guidelines. | Q38120131 | ||
| Mood disorders in the physically ill--problems of definition and measurement. | Q39568132 | ||
| Psychiatric disorder in the general hospital | Q39747709 | ||
| The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study | Q39973628 | ||
| Dangers of using "optimal" cutpoints in the evaluation of prognostic factors | Q40752297 | ||
| Management of Multiple Sclerosis | Q41644495 | ||
| Validation of a self-report comorbidity questionnaire for multiple sclerosis | Q44809985 | ||
| Infection with human immunodeficiency virus and vulnerability to psychiatric distress. A study of men with hemophilia | Q45848955 | ||
| Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis | Q46205108 | ||
| The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis | Q46744890 | ||
| Screening for depression among patients with multiple sclerosis: two questions may be enough | Q46767491 | ||
| Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures | Q47679966 | ||
| Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis | Q47679975 | ||
| Challenges in screening for depression in multiple sclerosis | Q48100305 | ||
| Beck Depression Inventory in the Detection of Depression among Neurological Inpatients | Q48414387 | ||
| Coverage of the bibliographic databases in mental health research | Q48419069 | ||
| Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis | Q48590271 | ||
| Neurovegetative symptoms in multiple sclerosis: relationship to depressed mood, fatigue, and physical disability | Q48614563 | ||
| The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes | Q48661398 | ||
| Assessment Of Depression In Multiple Sclerosis: Development Of A “Trunk And Branch” Model | Q49046491 | ||
| What do people think about when answering questionnaires to assess unrealistic optimism about skin cancer? A think aloud study | Q50879606 | ||
| Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients | Q50984760 | ||
| Psychometric evaluation of the C hicago Multiscale Depression Inventory in multiple sclerosis patients | Q51026601 | ||
| Mood disturbance versus other symptoms of depression in multiple sclerosis | Q51124592 | ||
| Clinical correlates of CES-D depressive symptom ratings in an MS population | Q51924417 | ||
| Psychiatric disorder in medical in-patients | Q52074694 | ||
| Measurement of depression in patients with cancer. | Q52092125 | ||
| Emotional disturbance in multiple sclerosis patients: validity of the General Health Questionnaire (GHQ) | Q52101642 | ||
| Endorsement of self-report neurovegetative items of depression is associated with multiple sclerosis disease symptoms | Q53525950 | ||
| Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives | Q56885135 | ||
| Predictive Value of the CES-D in Detecting Depression Among Candidates for Disease-Modifying Multiple Sclerosis Treatment | Q57244329 | ||
| Letter to the editor | Q58418349 | ||
| The acceptability of computerised cognitive behavioural therapy for the treatment of depression in people with chronic physical disease: A qualitative study of people with multiple sclerosis | Q59361951 | ||
| Screening for major depression in the early stages of multiple sclerosis | Q70805862 | ||
| Identifying randomized controlled trials of cognitive therapy for depression: comparing the efficiency of Embase, Medline and PsycINFO bibliographic databases | Q73313852 | ||
| Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis | Q73546324 | ||
| Identification of Beck Depression Inventory items related to multiple sclerosis | Q73700806 | ||
| Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis | Q75437684 | ||
| Psychometric Properties of the Center for Epidemiologic Studies-Depression Scale in Multiple Sclerosis | Q77089546 | ||
| Assessment of emotional problems in people with multiple sclerosis | Q77450252 | ||
| Assessing depressive symptoms in multiple sclerosis: is it necessary to omit items from the original Beck Depression Inventory? | Q77897535 | ||
| One question as a screening instrument for depression in people with multiple sclerosis | Q80573139 | ||
| Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients | Q84990004 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| mental health | Q317309 | ||
| mental depression | Q4340209 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 278 | |
| P577 | publication date | 2016-08-04 | |
| P1433 | published in | BMC Psychiatry | Q15750257 |
| P1476 | title | The assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studies | |
| P478 | volume | 16 |
| Q38691568 | Depression in multiple sclerosis |
| Q47552171 | Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study |
| Q64256084 | Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review |
| Q88543531 | Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4+ T-cell subsets in multiple sclerosis patients |
| Q55383149 | Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (MS)-A Longitudinal and Pilot Study. |
| Q90222204 | The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians |
| Q26765031 | The challenge of comorbidity in clinical trials for multiple sclerosis |
| Q59813202 | The hospital anxiety and depression scale, in patients with multiple sclerosis |
Search more.